This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revision | Next revisionBoth sides next revision | ||
home:diseases:ibs [03.13.2019] – [Headline] sallieq | home:diseases:ibs [03.13.2019] – [Further researxh] sallieq | ||
---|---|---|---|
Line 48: | Line 48: | ||
Free versus total serum 25-hydroxyvitamin D in a murine model of colitis. | Free versus total serum 25-hydroxyvitamin D in a murine model of colitis. | ||
- | ==== Further | + | ==== Further |
Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely. | Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely. |